https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-august-19-2026/ 2026-08-21T10:06:10Z Pharminent en Manufacturing Intelligence • Weekly Digest • August 19, 2026 2026-08-21T10:06:07Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-august-19-2026/ 2026-08-20T20:56:20Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • August 19, 2026 2026-08-20T20:56:18Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-august-18-2026/ 2026-08-20T20:54:45Z Pharminent en Oncology Intelligence Digest • August 18, 2026 2026-08-20T20:54:43Z Blog https://pharminent.com/regenerons-pasatru-wins-full-fda-approval-for-ultra-rare-stone-man-disease/ 2026-08-20T20:37:50Z Pharminent en Regeneron's Pasatru Wins Full FDA Approval for Ultra-Rare 'Stone Man Disease' 2026-08-20T20:36:52Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-20-2026/ 2026-08-20T18:47:56Z Pharminent en Strategic News Watch • August 20, 2026 2026-08-20T18:47:54Z Blog https://pharminent.com/cancer-vaccine-win-restores-wall-streets-faith-in-moderna/ 2026-08-21T10:28:31Z Pharminent en Cancer vaccine win restores Wall Street's faith in Moderna 2026-08-20T15:19:46Z Blog https://pharminent.com/ultragenyx-wins-fda-approval-for-first-treatment-targeting-root-cause-of-gsdia/ 2026-08-21T10:29:04Z Pharminent en Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa 2026-08-20T14:17:11Z Blog https://pharminent.com/moderna-and-mercks-personalized-melanoma-vaccine-scores-historic-phase-3-win/ 2026-08-20T18:59:00Z Pharminent en Moderna and Merck's Personalized Melanoma Vaccine Scores Historic Phase 3 Win 2026-08-19T19:13:23Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-19-2026/ 2026-08-19T18:54:51Z Pharminent en Strategic News Watch • August 19, 2026 2026-08-19T18:54:48Z Blog https://pharminent.com/trump-nominates-policy-aide-overton-to-lead-fda/ 2026-08-21T10:41:41Z Pharminent en Trump nominates policy aide Overton to lead FDA 2026-08-19T15:30:00Z Blog